Cellular Immunotherapy Treatments as a Standard of Care: Clinical Sites, Professional Societies, and Industry Collaboration to Minimize Redundancy

This is the recording and slides of the session presented live at the 2021 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Thursday, November 18, 2021. Topics include:

• ASTCT 80/20 Taskforce
• FACT/Industry Collaboration for Site Qualification
• Standardized Auditing Programs and Logistics Interface
• Streamlined Onboarding for Solid Tumor Therapies
• Shared FDA REMS Platform

Session Chairs: Dr. Sarah Nikiforow, MD (Dana Farber Cancer Institute) and Dr. Fred Locke, MD (Moffitt Cancer Center)

Speakers: Tracey Hlucky (Kite Pharma), Dr. Joy Aho, PhD (NMDP/Be The Match), Dr. Madan Jagasia, MD, MS (Iovance Biotherapeutics), and Dr. John-Peter Zak, PharmD, RPh (Janssen Pharmaceuticals)

Additional Panelists: Dr. Larissa Lapteva (FDA), Dr. Phyllis Warkentin, MD (FACT), and Dr. Marcelo Pasquini, MD, MS (CIBMTR and MCW Cancer Center)